Long Wu

2.3k total citations
50 papers, 1.8k citations indexed

About

Long Wu is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Long Wu has authored 50 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Cancer Research and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Long Wu's work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (7 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Long Wu is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (7 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Long Wu collaborates with scholars based in China, United States and Hong Kong. Long Wu's co-authors include Yafei Li, Na Wu, Ying Xiang, Yufeng Yuan, Li Zhong, Zhisu Liu, Tian Lan, Xiangyu Ma, Zhiyuan Song and Ganggang Wang and has published in prestigious journals such as PLoS ONE, Cell Metabolism and Scientific Reports.

In The Last Decade

Long Wu

47 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Long Wu China 25 842 531 277 259 251 50 1.8k
Quan Liu China 22 744 0.9× 380 0.7× 148 0.5× 95 0.4× 127 0.5× 101 1.5k
Lei Gao China 26 770 0.9× 414 0.8× 333 1.2× 294 1.1× 60 0.2× 110 1.8k
Zuo‐Lin Li China 23 1.7k 2.0× 704 1.3× 127 0.5× 64 0.2× 127 0.5× 70 2.7k
Anat Aharon Israel 25 1.0k 1.2× 333 0.6× 203 0.7× 209 0.8× 72 0.3× 57 1.9k
Angela L. Bergeron United States 20 356 0.4× 182 0.3× 631 2.3× 141 0.5× 150 0.6× 34 1.7k
Kichizo Kaga Japan 21 597 0.7× 165 0.3× 229 0.8× 267 1.0× 120 0.5× 95 1.8k
Tao‐Tao Tang China 27 2.2k 2.7× 742 1.4× 165 0.6× 78 0.3× 153 0.6× 63 3.5k
Karen Meir Israel 20 502 0.6× 217 0.4× 121 0.4× 182 0.7× 78 0.3× 67 1.6k
Yi Gao China 22 690 0.8× 266 0.5× 65 0.2× 273 1.1× 87 0.3× 87 1.4k

Countries citing papers authored by Long Wu

Since Specialization
Citations

This map shows the geographic impact of Long Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Long Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Long Wu more than expected).

Fields of papers citing papers by Long Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Long Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Long Wu. The network helps show where Long Wu may publish in the future.

Co-authorship network of co-authors of Long Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Long Wu. A scholar is included among the top collaborators of Long Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Long Wu. Long Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Long, et al.. (2025). Mitochondrial VHL rewires cell metabolism in hypoxia. Cell Metabolism. 38(1). 174–191.e7.
2.
Sun, Xinhai, Wen-Wei Lin, Yan-yan Zhan, et al.. (2025). Genomic profiles and prognostic biomarkers of resectable lung adenocarcinoma with a micropapillary component. Frontiers in Oncology. 15. 1574817–1574817.
3.
Wang, Na, Cong Yao, Changliang Luo, et al.. (2023). Integrated plasma and exosome long noncoding RNA profiling is promising for diagnosing non-small cell lung cancer. Clinical Chemistry and Laboratory Medicine (CCLM). 61(12). 2216–2228. 13 indexed citations
4.
Cao, Yi, Chen Xu, Chunyan Yao, et al.. (2022). Elder people can be more susceptible to the association between short-term ambient air pollution and sleep disorder outpatient visits: a time-series study. Environmental Science and Pollution Research. 29(43). 64902–64913. 4 indexed citations
6.
Wu, Long, Wei Xie, Zhongzhong Liu, et al.. (2020). Platelet membrane-coated nanoparticles for targeted drug delivery and local chemo-photothermal therapy of orthotopic hepatocellular carcinoma. Journal of Materials Chemistry B. 8(21). 4648–4659. 76 indexed citations
7.
Ma, Weijie, Daoming Zhu, Jinghua Li, et al.. (2020). Coating biomimetic nanoparticles with chimeric antigen receptor T cell-membrane provides high specificity for hepatocellular carcinoma photothermal therapy treatment. Theranostics. 10(3). 1281–1295. 185 indexed citations
8.
Wu, Na, Ying Xiang, Long Wu, et al.. (2020). Prognostic value of chemokines in patients with newly diagnosed atrial fibrillation. International Journal of Cardiology. 320. 83–89. 11 indexed citations
9.
Yuan, Shuai, Ying Xiang, Yao Zhang, et al.. (2020). Circulating Long Noncoding RNAs Act as Diagnostic Biomarkers in Non-Small Cell Lung Cancer. Frontiers in Oncology. 10. 537120–537120. 22 indexed citations
10.
Luo, Changliang, Yuan Rong, Hao Chen, et al.. (2019). A Logistic Regression Model for Noninvasive Prediction of AFP-Negative Hepatocellular Carcinoma. Technology in Cancer Research & Treatment. 18. 1078114280–1078114280. 19 indexed citations
11.
Liang, Zhen, Chen Xu, Yi Cao, et al.. (2018). The association between short-term ambient air pollution and daily outpatient visits for schizophrenia: A hospital-based study. Environmental Pollution. 244. 102–108. 64 indexed citations
12.
Li, Jinghua, Weijie Ma, Ganggang Wang, et al.. (2018). Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis. Frontiers in Immunology. 9. 2077–2077. 29 indexed citations
13.
Zhu, Chengliang, et al.. (2017). Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA. Lipids in Health and Disease. 16(1). 5–5. 9 indexed citations
14.
Qin, Xian, Jing Chen, Long Wu, & Zhisu Liu. (2017). MiR-30b-5p acts as a tumor suppressor, repressing cell proliferation and cell cycle in human hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 89. 742–750. 46 indexed citations
15.
Wu, Long, Junying Zheng, Ping Chen, Quanyan Liu, & Yufeng Yuan. (2017). Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway. Biomedicine & Pharmacotherapy. 90. 705–712. 50 indexed citations
16.
Lan, Tian, et al.. (2016). Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma. Medicine. 95(15). e3185–e3185. 33 indexed citations
17.
Xiang, Ying, Na Wu, Long Wu, et al.. (2015). A Comparison of Laparoscopy and Laparotomy for the Management of Abdominal Trauma: A Systematic Review and Meta‐analysis. World Journal of Surgery. 39(12). 2862–2871. 37 indexed citations
18.
Wu, Na, Tong Shi-fei, Ying Xiang, et al.. (2015). Association of Hemostatic Markers with Atrial Fibrillation: A Meta-Analysis and Meta-Regression. PLoS ONE. 10(4). e0124716–e0124716. 42 indexed citations
19.
Wu, Na, Bin Xu, Ying Xiang, et al.. (2013). Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: A meta-analysis. International Journal of Cardiology. 169(1). 62–72. 180 indexed citations
20.
Wu, Long, Jinxuan Hou, Chun‐Wei Peng, et al.. (2010). [Increased coronin-1C expression is related to hepatocellular carcinoma invasion and metastasis].. PubMed. 18(7). 516–9. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026